| BAU | Binding antibody units |
| BMI | Body Mass Index |
| CASCO | Centre of High Specialisation for the Cure of Obesity |
| CD | Cluster of differentiation |
| CVID | Common Variable Immunodeficiency |
| ED | Emergency Department |
| GMC | Geometric mean concentration |
| GMT | Geometric Mean Titre |
| Grab | Granzyme B |
| HA | Hemagglutinin |
| HAI | Hemagglutination Inhibiting Antibody |
| HI | Hemagglutination Inhibition |
| HIV | Human Immunodeficiency Virus |
| HDL | High-Density Lipoprotein |
| IFN | Interferon |
| IFN | Gamma |
| IFNγ | Interferon-gamma |
| IgG | Immunoglobulin G |
| IIV | Inactivated Influenza Vaccine |
| IL-10 | Interleukin-10 |
| IL-6 | Interleukin-6 |
| IL12R | Interleukin 12 Receptor |
| ILI | Influenza-like Illness |
| LAIV | Live Attenuated Influenza Vaccine |
| MCP-1 | Monocyte Chemoattractant protein-1 |
| MHC-II | Major Histocompatibility Complex-II |
| MHOO | Healthy Metabolic Phenotypes |
| MUOO | Unhealthy Metabolic Phenotypes |
| NA | Neuraminidase |
| NK cells | Natural Killer Cells |
| PBMC | Peripheral Blood Mononuclear Cell |
| RIV | Recombinant Influenza Vaccine |
| TCR | T-cell receptor |
| TIV | Trivalent Influenza Vaccine |
| TNF-alpha | Tumour necrosis factor-alpha |
| QIV | Quadrivalent Influenza Vaccine |
| S1/S2 | Spike Glycoprotein |
| WHO | World Health Organisation |